Overall | Aspirin ever | No aspirin | P -value | |
---|---|---|---|---|
(n = 202) | (n = 56, 28%) | (n = 146, 72%) | ||
Age | ||||
Median | 61 | 71 | 56 | <0.001* |
IQR | 46 to 71 | 60 to 77 | 41 to 68 | |
Male | ||||
Number (%) | 129 (64) | 40 (71) | 89 (61) | 0.17 |
APACHE II score | ||||
Median | 19 | 21 | 18 | 0.10 |
IQR | 14 to 24 | 17 to 24 | 13 to 24 | |
SOFA | ||||
Median | 8 | 8 | 8 | 0.99 |
IQR | 6 to 11 | 7 to 11 | 6 to 11 | |
PaO2/FiO2 ratio | ||||
Median | 22.9 | 21.1 | 23.5 | 0.08 |
IQR | 17 to 30 | 16 to 27 | 18 to 31 | |
Vasopressor use | ||||
Number (%) | 95 (47) | 30 (54) | 65 (45) | 0.25 |
Sepsis | ||||
Number (%) | 111 (55) | 29 (52) | 82 (56) | 0.58 |
Coronary artery disease | ||||
N (%) | 33 (16) | 22 (39) | 11 (8) | <0.001 |
Cerebrovascular disease | ||||
Number (%) | 12 (6) | 9 (16) | 3 (2) | 0.001* |
COPD | ||||
Number (%) | 29 (14) | 13 (23) | 16 (11) | 0.02* |
Diabetes mellitus | ||||
Number (%) | 30 (15) | 18 (32) | 12 (8) | <0.001* |
Smoker | ||||
Number (%) | 99 (49) | 34 (61) | 65 (45) | 0.04* |
Alcohol abuse/liver cirrhosis | ||||
Number (%) | 58 (29) | 9 (16) | 49 (34) | 0.01* |
Pre-admission statin | ||||
Number (%) | 61 (30) | 37 (66) | 24 (16) | <0.001* |